NueHealth, GeneNews partner to offer patients early CRC detection: 3 notes

NueHealth has entered a three-year partnership agreement with GeneNews — a Canadian diagnostic products company — to offer its patients early cancer detection tests.

Here's what you need to know:

1. Patients of NueHealth's provider networks will have access to three screening types, including ColonSentry, a screening test that provides early risk stratification for colorectal cancer.

2. ColonSentry utilizes a blood test, which measures the expression of gene biomarkers that are early warning signs of colorectal cancer.

3. The tests will be processed by GeneNews at a clinical reference lab in Richmond, Va.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast